Dr. John Cush RheumNow
3 years 5 months ago
Analysis of 886 SpA pts in the Ankylosing Spondylitis Registry of Ireland shows women have worse BASDAI (4.57 vs 3.83, p < 0.01) & ASQoL (7.51 vs 6.12, p < 0.01) scores than males. higher scores in females due to all 6 BASDAI components https://t.co/2kt6t9MXUB https://t.co/o056cgF43V
Are antiphospholipid antibodies (aPL) associated with atherosclerotic cardiovascular (ASCVD) event risk? A cohort study has shown that aPL Abs are found in a substantial proportion of adults with ASCVD events and finding both positive aCL IgA and aβ2GPI IgA Abs independently predicted future ASCVD events.
Dr. John Cush RheumNow
3 years 5 months ago
Pooled data from 3 RCTs in PsA compared tofacitinib vs. adalimumab in 816 pts. Baseline, women had higher TJC, enthesitis, HAQ-DI, FACIT-F (Males more dactylitis). Sexes had equal ACR20/50/70, PASI75, ∆HAQ-DI, & persistence, but females less achieved MDA https://t.co/LICWVjI2kH https://t.co/8RipVIEWyJ
As I was training as a rheumatologist, I found myself drawn to rheumatologic disorders in older patients. In particular, I was intrigued by programmatic development that could improve both disease outcomes and older adults’ quality of life. This was not the “sexiest” topic in rheumatology and it was hard to figure out how to get started. I was extremely fortunate to find a mentor.
Dr. John Cush RheumNow
3 years 5 months ago
British Society of Rheumatology Plans Revision of Systemic Sclerosis Guideline
BSR last published its guideline for SSc in 2016. Given the many advances in the field the BSR has outlined their plans to update the management of SSc.
https://t.co/AlMOamGV5y https://t.co/d9RtWE4s0S
Dr. John Cush RheumNow
3 years 5 months ago
Our next Tuesday Night Rheumatology addresses Contract Negotiations, featuring Andrea Liberatore, JD, Gwenesta Melton, MD, and Kathryn Dao, MD.
Sign up to attend this and all of our Tuesday Night Rheumatology series.
@uptoTate @KDAO2011
https://t.co/z03KKCMpzE https://t.co/h6auLqwaE7
Dr. John Cush RheumNow
3 years 5 months ago
Inflammasome inhibitors in development:
- RRx-001 in cancer, ALS, parkinsons
- OLT1177 in OA knee, gout, Schnitzlers
- DFV890 in CAPs, knee OA
- IZD174/334 in CAPS
- ZYIL1 CAPS
https://t.co/7E2jdx9TPA https://t.co/R5Uu5mjIym
Sensitive women and stoical men are the prevalent images of people in chronic pain. Unwarranted differences in medical treatment may result, as a University of Gothenburg doctoral thesis emphasizes.
Dr. John Cush RheumNow
3 years 5 months ago
US MD survey shows # active MDs grew 33% to 923 419 (2001-2021). But AVG weekly work hrs declined 7.6% (53 to 49 hrs/wk). Decline driven by MD males/Fathers (-12%), rural MDs, 45-54 yrs old MDs. Only MD mothers had signif. increase in work hours (+3%) https://t.co/1CR2ERPX5e https://t.co/at0RJpcTEp
Dr. John Cush RheumNow
3 years 5 months ago
962 #RA pts from Leiden early arthritis clinic shows that in 2005 was a significant delay (~5wks) in referral of females vs male pts. The longer referral delays in female pts has since been eliminated. By 2020 the referral delay is same 4.7 vs 5.4 wks. https://t.co/JphiWWk85j https://t.co/bEHKLot4hu
Janet Pope Janetbirdope
3 years 5 months ago
It is not only ‘OK’ to say no but mandatory for self preservation! https://t.co/KWTHuvtLpb
Fibromyalgia is a mysterious chronic pain disorder that is difficult to treat. Its causes are also still largely in the dark. A study conducted by the team at the Clinic for Psychosomatic Medicine and Psychotherapy at Ruhr University Bochum, Germany, provides evidence that certain brain areas involved in processing pain don’t function normally in fibromyalgia patients.
Dr. John Cush RheumNow
3 years 5 months ago
EMA Final Update on JAK Inhibitors and MACE, Malignancy & VTE Risks
https://t.co/rMEqodKdVN https://t.co/OT0gRRADIc
Dr. John Cush RheumNow
3 years 5 months ago
The Origin Story: Women in Rheumatology--The XX Factor
When asked to run a campaign to highlight the achievements and challenges of women in rheumatology, I was ecstatic because we have has so many heroines who have contributed to our field.
https://t.co/ucQIPjQ8Tu https://t.co/g81EtAwYYL

